<!DOCTYPE html>
<html lang="en-US"><head>
		<meta charset="UTF-8">
		<title>FR940202-2-00052</title>
	</head>
	<body>
		<main>
			<p><!-- PJG STAG 4703 -->  <!-- PJG ITAG l=69 g=1 f=1 -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=18 g=1 f=1 -->  <USBUREAU>Centers for Disease Control and Prevention</USBUREAU> <!-- PJG /ITAG -->  <!-- PJG ITAG l=55 g=1 f=1 -->  <DOCTITLE>Hospital Infection Control Practices Advisory Committee: Subcommittee on Prevention and Control of Antimicrobial Resistant Microorganisms in Hospitals; Meeting</DOCTITLE> <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92&hyph;463), the Centers for Disease Control and Prevention (CDC) announces the following subcommittee meeting. <!-- PJG /ITAG -->  <!-- PJG QTAG 04 --> <!-- PJG /QTAG -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG ITAG l=21 g=1 f=1 -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=3 --> Name:  <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=1 --> Subcommittee on Prevention and Control of Antimicrobial Resistant Microorganisms in Hospitals. <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=3 --> Time and Date:  <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=1 --> 9 a.m.&hyph;3:30 p.m., February 18, 1994. <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=3 --> Place:  <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=1 --> CDC, Auditorium A, 1600 Clifton Road, NE., Atlanta, Georgia 30333. <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=3 --> Status:  <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=1 --> Open to the public, limited only by the space available. <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=3 --> Purpose:  <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=1 --> This subcommittee will review current knowledge about the epidemiology and laboratory aspects of antimicrobial resistance among nosocomial pathogens and develop an agenda for a workshop later this year to revise and/or develop recommendations to control these pathogens in acute care settings. <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=3 --> Matters to be Discussed:  <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=1 --> The subcommittee will hold its second meeting to review current knowledge about the epidemiology and laboratory aspects of vancomycin resistance in enterococci and develop a comprehensive strategic plan to detect, prevent, and control resistant enterococci in U.S. hospitals. Agenda items are subject to change as priorities dictate. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=3 --> Contact Person for More Information:  <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=1 --> Julia S. Garner, R.N., M.N., Nurse Consultant, Hospital Infections Program, NCID, CDC, 1600 Clifton Road, NE., Mailstop A&hyph;07, Atlanta, Georgia 30333, telephone 404/639&hyph;1552. <!-- PJG /ITAG -->  <!-- PJG QTAG 02 --> <!-- PJG /QTAG -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG ITAG l=21 g=1 f=1 --> Dated: January 27, 1994. <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <SIGNER> <!-- PJG ITAG l=06 g=1 f=1 --> Elvin Hilyer, <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG --> </SIGNER> <SIGNJOB> <!-- PJG ITAG l=04 g=1 f=1 --> Associate Director for Policy Coordination, Centers for Disease Control and Prevention (CDC). <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG --> </SIGNJOB> <FRFILING> <!-- PJG ITAG l=40 g=1 f=1 --> [FR Doc. 94&hyph;2330 Filed 2&hyph;1&hyph;94; 8:45 am] <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG --> </FRFILING> <BILLING> <!-- PJG ITAG l=68 g=1 f=1 --> BILLING CODE 4160&hyph;18&hyph;M <!-- PJG /ITAG --> </BILLING>  <!-- PJG 0012 frnewline -->  <!-- PJG /STAG --></p>
		</main>
</body></html>
            